229 related articles for article (PubMed ID: 34415953)
1. Socioeconomic position is associated with N-terminal pro-brain natriuretic peptide (NT-proBNP)-Results of the population-based Heinz Nixdorf Recall study.
Rudman M; Frank M; Emmel C; Matusch E; Kara K; Mahabadi AA; Erbel R; Jöckel KH; Dragano N; Schmidt B
PLoS One; 2021; 16(8):e0255786. PubMed ID: 34415953
[TBL] [Abstract][Full Text] [Related]
2. Impact of socioeconomic and cardiovascular risk factors on the effect of genetic variants associated with NT-proBNP.
Matusch E; Frank M; Kara K; Mahabadi AA; Dragano N; Erbel R; Jöckel KH; Schmidt B
Sci Rep; 2022 Sep; 12(1):15560. PubMed ID: 36114409
[TBL] [Abstract][Full Text] [Related]
3. A cross sectional study comparing traditional risk factors with N-terminal pro-BNP in high risk groups for cardiovascular disease in Trinidad, West Indies.
Shivananda Nayak B; Teelucksingh S; Jagessar A; Maharaj S; Maharaj N
Diabetes Metab Syndr; 2013; 7(1):8-11. PubMed ID: 23517788
[TBL] [Abstract][Full Text] [Related]
4. Association of NT-ProBNP, Blood Pressure, and Cardiovascular Events: The ARIC Study.
Hussain A; Sun W; Deswal A; de Lemos JA; McEvoy JW; Hoogeveen RC; Matsushita K; Aguilar D; Bozkurt B; Virani SS; Shah AM; Selvin E; Ndumule C; Ballantyne CM; Nambi V
J Am Coll Cardiol; 2021 Feb; 77(5):559-571. PubMed ID: 33538254
[TBL] [Abstract][Full Text] [Related]
5. Effects of Canagliflozin on Amino-Terminal Pro-B-Type Natriuretic Peptide: Implications for Cardiovascular Risk Reduction.
Januzzi JL; Xu J; Li J; Shaw W; Oh R; Pfeifer M; Butler J; Sattar N; Mahaffey KW; Neal B; Hansen MK
J Am Coll Cardiol; 2020 Nov; 76(18):2076-2085. PubMed ID: 33121714
[TBL] [Abstract][Full Text] [Related]
6. Relation of NT-probnp levels and cardiovascular disease risk factors in lean women with polycystic ovary syndrome.
Karadağ C; Yoldemir T
J Obstet Gynaecol; 2019 Nov; 39(8):1154-1159. PubMed ID: 31215274
[TBL] [Abstract][Full Text] [Related]
7. N-terminal pro-B-type natriuretic peptide and the prediction of primary cardiovascular events: results from 15-year follow-up of WOSCOPS.
Welsh P; Doolin O; Willeit P; Packard C; Macfarlane P; Cobbe S; Gudnason V; Di Angelantonio E; Ford I; Sattar N
Eur Heart J; 2013 Feb; 34(6):443-50. PubMed ID: 22942340
[TBL] [Abstract][Full Text] [Related]
8. N-terminal pro-brain natriuretic peptide and risk of cardiovascular events in older patients with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.
Price AH; Welsh P; Weir CJ; Feinkohl I; Robertson CM; Morling JR; McLachlan S; Strachan MW; Sattar N; Price JF
Diabetologia; 2014 Dec; 57(12):2505-12. PubMed ID: 25231020
[TBL] [Abstract][Full Text] [Related]
9. NT-proBNP is superior to BNP for predicting first cardiovascular events in the general population: the Heinz Nixdorf Recall Study.
Kara K; Lehmann N; Neumann T; Kälsch H; Möhlenkamp S; Dykun I; Broecker-Preuss M; Pundt N; Moebus S; Jöckel KH; Erbel R; Mahabadi AA
Int J Cardiol; 2015 Mar; 183():155-61. PubMed ID: 25666125
[TBL] [Abstract][Full Text] [Related]
10. Associations of High-Sensitivity Cardiac Troponin and Natriuretic Peptide With Subsequent Risk of Infection in Persons Without Cardiovascular Disease: The Atherosclerosis Risk in Communities Study.
Ishigami J; Hoogeveen RC; Ballantyne CM; Folsom AR; Coresh J; Selvin E; Matsushita K
Am J Epidemiol; 2019 Dec; 188(12):2146-2155. PubMed ID: 31063194
[TBL] [Abstract][Full Text] [Related]
11. Urinary N-terminal pro-B-type natriuretic peptide as a biomarker for cardiovascular events in a general Japanese population: the Hisayama Study.
Yamasaki K; Hata J; Ide T; Nagata T; Sakata S; Yoshida D; Honda T; Hirakawa Y; Nakano T; Kitazono T; Tsutsui H; Ninomiya T
Environ Health Prev Med; 2021 Apr; 26(1):47. PubMed ID: 33845756
[TBL] [Abstract][Full Text] [Related]
12. N-Terminal Pro-B Type Natriuretic Peptide is Associated with Mild Cognitive Impairment in the General Population.
Kara K; Mahabadi AA; Weimar C; Winkler A; Neumann T; Kälsch H; Dragano N; Moebus S; Erbel R; Jöckel KH; Jokisch M
J Alzheimers Dis; 2017; 55(1):359-369. PubMed ID: 27636851
[TBL] [Abstract][Full Text] [Related]
13. Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis.
Natriuretic Peptides Studies Collaboration ; Willeit P; Kaptoge S; Welsh P; Butterworth AS; Chowdhury R; Spackman SA; Pennells L; Gao P; Burgess S; Freitag DF; Sweeting M; Wood AM; Cook NR; Judd S; Trompet S; Nambi V; Olsen MH; Everett BM; Kee F; Ärnlöv J; Salomaa V; Levy D; Kauhanen J; Laukkanen JA; Kavousi M; Ninomiya T; Casas JP; Daniels LB; Lind L; Kistorp CN; Rosenberg J; Mueller T; Rubattu S; Panagiotakos DB; Franco OH; de Lemos JA; Luchner A; Kizer JR; Kiechl S; Salonen JT; Goya Wannamethee S; de Boer RA; Nordestgaard BG; Andersson J; Jørgensen T; Melander O; Ballantyne ChM; DeFilippi Ch; Ridker PM; Cushman M; Rosamond WD; Thompson SG; Gudnason V; Sattar N; Danesh J; Di Angelantonio E
Lancet Diabetes Endocrinol; 2016 Oct; 4(10):840-9. PubMed ID: 27599814
[TBL] [Abstract][Full Text] [Related]
14. Systemic Inflammation and Cardio-Renal Organ Damage Biomarkers in Middle Age Are Associated With Physical Capability Up to 9 Years Later.
Kuh D; Cooper R; Sattar N; Welsh P; Hardy R; Ben-Shlomo Y
Circulation; 2019 Apr; 139(17):1988-1999. PubMed ID: 30667283
[TBL] [Abstract][Full Text] [Related]
15. Serial measurement of N-terminal pro-B-type natriuretic peptide and cardiac troponin T for cardiovascular disease risk assessment in the Multi-Ethnic Study of Atherosclerosis (MESA).
Daniels LB; Clopton P; deFilippi CR; Sanchez OA; Bahrami H; Lima JA; Tracy RP; Siscovick D; Bertoni AG; Greenland P; Cushman M; Maisel AS; Criqui MH
Am Heart J; 2015 Dec; 170(6):1170-83. PubMed ID: 26678639
[TBL] [Abstract][Full Text] [Related]
16. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P
JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980
[TBL] [Abstract][Full Text] [Related]
17. Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study.
Daniels LB; Laughlin GA; Clopton P; Maisel AS; Barrett-Connor E
J Am Coll Cardiol; 2008 Aug; 52(6):450-9. PubMed ID: 18672166
[TBL] [Abstract][Full Text] [Related]
18. N-terminal prohormone brain natriuretic peptide as a predictor of cardiovascular disease and mortality in blacks with hypertensive kidney disease: the African American Study of Kidney Disease and Hypertension (AASK).
Astor BC; Yi S; Hiremath L; Corbin T; Pogue V; Wilkening B; Peterson G; Lewis J; Lash JP; Van Lente F; Gassman J; Wang X; Bakris G; Appel LJ; Contreras G
Circulation; 2008 Apr; 117(13):1685-92. PubMed ID: 18362234
[TBL] [Abstract][Full Text] [Related]
19. The value of N-terminal pro-B-type natriuretic peptide in determining antihypertensive benefit: observations from the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT).
Welsh P; Poulter NR; Chang CL; Sever PS; Sattar N;
Hypertension; 2014 Mar; 63(3):507-13. PubMed ID: 24324046
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of B-type Natriuretic Peptides to Predict Cardiovascular Events in Women (from the Women's Health Study).
Everett BM; Ridker PM; Cook NR; Pradhan AD
Am J Cardiol; 2015 Aug; 116(4):532-7. PubMed ID: 26081066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
